- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06119113
Evaluation of Wound Infection Rates and Cosmetic Results of Different Suture Materials in Cesarean Skin Incision
Evaluation of Wound Site Infection,Early and Late Wound Healing and Cosmetic Results of Vicryl ,Monocryl and Prolene Suture Materials Used in Pfannenstiel Skin Incision in Caesarean Section
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Evaluation of the wound infection at the 10th day post-op check-up among all groups
- Other: Evaluation of the cosmetic results of the incision line at the 2nd month post-op check-up among all groups
- Other: Evaluation of the cosmetic results of the incision line at the 6th month post-op check-up among all groups
Detailed Description
Patients who met the inclusion criteria among patients who had a cesarean delivery (January 2023-June 2023) in our hospital within a 6-month period will be included in the study. Patients included in the study will be randomized and divided into three randomized groups as Vicryl (Polyglactin 910), Monocryl (Polyglecaprone 25) and Prolene (polypropylene) to be administered. Each cesarean section technique will be left to the discretion of the surgeon performing the operation, and cefazolin 2 g will be administered prophylactically half an hour before each procedure in our clinic. In all cases, a Pfannenstiel skin incision will be made 2 cm above the pubic symphysis. Following delivery of the fetus, the uterus, peritoneum, and fascia will be closed in sequence. The skin will be sealed with Vicryl (Polyglactin 910), Monocryl (Polyglecaprone 25), and Prolene (polypropylene) according to randomization. The dressing will be removed on the first day after the operation and the patients will be discharged on the second post-op day if there is no problem after the operation. Patients will be called for control on the 10th , 60th and 120th days of pos op. If the post op 10th day is deemed appropriate, the sutures of the patients in the prolene suture group will be removed. All groups that come to the control will be evaluated with the patient and the observer doctor by the patient and observer rating scale (POSAS) and the Vancouver Scar Scale (VSS).
The Patient and Observer Rating Scale (POSAS) is a questionnaire developed to assess scar quality. It consists of a five-observer and six-patient scale (Observer and Patient Scales) according to the rating scale based on clinically relevant scar characteristics [ Draaijers LJ, 2004 , Van de Kar AL, 2005]. Observer ; scores six items: vascularization, pigmentation, thickness, surface roughness, flexibility, and surface area. Patient ; it scores six items: pain, itching, color, thickness, relief and flexibility [Van de Kar AL , 2005]. All included items are scored on a multiple 10-point scale where 1 point is given when the wound feature is similar to 'normal skin' and 10 points are awarded when it reflects the 'worst scar'. All items are summed to determine the total scar score, with a higher score representing worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity, and pigmentation. The total score ranges from 0 to 14, with a score of 0 reflecting normal skin
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Başakşehir
-
Istanbul, Başakşehir, Turkey (Türkiye), 00034
- Başakşehir Çam ve Sakura Şehir Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-45 years old
- Patients who had a primary cesarean section at our >37w hospital
- Patients with a Pfannenstiel incision closed subcutaneously
Exclusion Criteria:
- Women <18 years and >45 years old
- Those with a history of keloid
- Suprapubic incision due to previous surgery
- Signs of infection at or near the incision during cesarean section
- Known hypersensitivity to any of the suture materials used
- Having a medical condition that causes immunosuppression, such as DM, chronic corticosteroid use
- Failure to obtain informed consent from the patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group 1 (Vicryl suture™(Polyglactin 910))
The group whose skin incision was closed with Vicryl suture™ (Polyglactin 910) from patients who had cesarean section for the first time
|
Discharge, redness, increased temperature, and dehiscence were accepted as wound infection.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
|
|
Active Comparator: Group 2 (Prolene suture™(polypropylene))
The group whose skin incision was closed with Prolene suture™ (polypropylene) from patients who had cesarean section for the first time
|
Discharge, redness, increased temperature, and dehiscence were accepted as wound infection.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
|
|
Active Comparator: Group 3 (Monocryl suture™ (Polyglecaprone 25))
The group whose skin incision was closed with Tekmon suture™ (Polyglecaprone 25) from patients who had cesarean section for the first time
|
Discharge, redness, increased temperature, and dehiscence were accepted as wound infection.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
The cosmetic outcome of wound site scar healing was evaluated with two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess scar quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, relief, and flexibility.
All items are scored on a 10-point multiple scale; A score of 1 is given when the scar characteristic is similar to 'normal skin' and a score of 10 is given when it reflects the 'worst scar'.
All items are summed to determine the total scar score; a higher score represents worse scar quality.
The Vancouver scar scale (VSS) consists of four variables: vascularity, height (thickness), elasticity and pigmentation.
The total score ranges from 0 to 14, with a score of 0 reflecting normal skin.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the Difference Between the Groups in the Number of Patients With Wound Infection at the End of the 10th Postoperative Day
Time Frame: 0-10. day
|
At the 10th postoperative day follow-up, discharge, redness, increased temperature and wound opening were considered as wound infection.
|
0-10. day
|
|
Comparison of Incision Cosmetic Results Between Group 1 (Vicryl Suture™(Polyglactin 910)) and Group 2 (Prolene Suture™(Polypropylene)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS
Time Frame: End of the 2nd month and 6th month
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6th month
|
|
Comparison of Incision Cosmetic Results Between Group 1 (Vicryl Suture™(Polyglactin 910)) and Group 3 (Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS
Time Frame: End of the 2nd month and 6thmonth
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6thmonth
|
|
Comparison of Incision Cosmetic Results Between Group 2 (Prolene Suture™(Polypropylene)) and Group 3 (Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by POSAS
Time Frame: End of the 2nd month and 6thmonth
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6thmonth
|
|
Comparison of Incision Cosmetic Results Between Group 1(Vicryl Suture™(Polyglactin 910)) and Group 2(Prolene Suture™(Polypropylene)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale (VSS)
Time Frame: End of the 2nd month and 6th month
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6th month
|
|
Comparison of Incision Cosmetic Results Between Group 1(Vicryl Suture™(Polyglactin 910)) and Group 3(Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale(VSS)
Time Frame: End of the 2nd month and 6th month
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6th month
|
|
Comparison of Incision Cosmetic Results Between Group 2(Prolene Suture™(Polypropylene)) and Group 3(Tekmon Suture™(Poliglekapron 25)) at the End of the 2nd Postoperative Month and at the End of the 6th Postoperative Month by The Vancouver Scar Scale(VSS)
Time Frame: End of the 2nd month and 6th month
|
The cosmetic outcome of wound healing was assessed using two different scales.
The Patient and Observer Assessment Scale (POSAS) is a questionnaire developed to assess wound quality.
The investigator scores six items: vascularization, pigmentation, thickness, surface roughness, elasticity, and surface area.
The participant scores six items: pain, itching, color, thickness, elevation, and elasticity.
All items are scored on a 10-point scale; 1 point is given when the wound characteristic is similar to 'normal skin', and 10 points are given when it reflects the 'worst wound'.
The total score closest to normal skin is 11, and the total score reflecting the worst wound is 110.
The other scale is the Vancouver Wound Scale (VSS), consisting of four variables: vascularity, height (thickness), elasticity, and pigmentation.
The total score ranges from 0 to 13, with 0 reflecting normal skin and 13 reflecting the worst wound.
|
End of the 2nd month and 6th month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ayşenur ÇALIŞ ÖZBAYRAM, yok
Publications and helpful links
General Publications
- Cromi A, Ghezzi F, Gottardi A, Cherubino M, Uccella S, Valdatta L. Cosmetic outcomes of various skin closure methods following cesarean delivery: a randomized trial. Am J Obstet Gynecol. 2010 Jul;203(1):36.e1-8. doi: 10.1016/j.ajog.2010.02.001. Epub 2010 Apr 24.
- Buresch AM, Van Arsdale A, Ferzli M, Sahasrabudhe N, Sun M, Bernstein J, Bernstein PS, Ngai IM, Garry DJ. Comparison of Subcuticular Suture Type for Skin Closure After Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol. 2017 Sep;130(3):521-526. doi: 10.1097/AOG.0000000000002200.
- Koroglu N, Temel Yuksel I, Aslan Cetin B, Aytufan Z, Deniz N, Akca A, Yetkin Yildirim G, Yuksel A. Skin closure at cesarean section, polypropylene versus polyglactin 910: a randomized controlled study. J Matern Fetal Neonatal Med. 2022 Mar;35(6):1088-1092. doi: 10.1080/14767058.2020.1743654. Epub 2020 Mar 30.
- Byrne M, Aly A. The Surgical Suture. Aesthet Surg J. 2019 Mar 14;39(Suppl_2):S67-S72. doi: 10.1093/asj/sjz036.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- basaksehircamvesakurasehirh
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scar
-
University of California, DavisCompletedLinear Scar | Zigzag ScarUnited States
-
Wake Forest University Health SciencesCompleted
-
Capstone TherapeuticsCompletedScar Prevention | Scar ReductionUnited States
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Iran University of Medical SciencesRecruitingDry Needling | Scar Tissue | Hypertrophic Scar | Hypertrophic Surgical Scar | Hypertrophic Scar of Upper Arm (Disorder)United States, Iran, Islamic Republic of
-
Maternal and Child Health Hospital of FoshanWithdrawn
-
Lumenis Be Ltd.Terminated
-
Riphah International UniversityRecruiting
-
CellinCellsNot yet recruiting
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States